Company Filing History:
Years Active: 2018-2020
Title: Daniela Smejkalova: Innovator in Antitumor Compositions
Introduction
Daniela Smejkalova is a prominent inventor based in Pisek, Czech Republic. She has made significant contributions to the field of biomedical innovations, particularly in the development of antitumor compositions. With a total of 2 patents, her work focuses on utilizing hyaluronic acid and inorganic nanoparticles for therapeutic applications.
Latest Patents
Her latest patents include an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. This innovative composition serves as a carrier for inorganic nanoparticles, which can include superparamagnetic nanoparticles and nanoparticles of ZnO. The composition has shown selective cytotoxic effects against various tumor cell lines, including those associated with colorectal carcinoma, lung carcinoma, and breast adenocarcinoma. The highest cytotoxic effects were observed with a composition based on an oleyl derivative of hyaluronan combined with SPIONs. Additionally, her work includes a method for preparing hydrophobized hyaluronic acid and encapsulating biologically active substances into nanomicelles, which can enhance the delivery of these substances in pharmaceutical and cosmetic applications.
Career Highlights
Daniela Smejkalova is currently employed at Contipro A.S., where she continues to advance her research in the field of nanomedicine. Her innovative approaches have positioned her as a key figure in the development of new therapeutic strategies.
Collaborations
Some of her notable coworkers include Kristina Nesporova and Gloria Huerta-Angeles, who collaborate with her on various research projects.
Conclusion
Daniela Smejkalova's contributions to the field of antitumor compositions highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic options in cancer treatment.